Ray Dalio's BHC Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 436,553 shares of Bausch Health Companies Inc. (BHC) worth $2.82 M, representing 0.01% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 307,068 shares. Largest reduction occurred in Q3 2025, reducing 308,010 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2018 | +169,886 | New Buy | 169,886 | $25.66 |
| Q4 2018 | -27,814 | Reduce 16.37% | 142,072 | $18.49 |
| Q1 2019 | -26,660 | Reduce 18.77% | 115,412 | $24.68 |
| Q4 2019 | -846 | Reduce 0.73% | 114,566 | $29.97 |
| Q1 2020 | -1,309 | Reduce 1.14% | 113,257 | $15.32 |
| Q2 2020 | -113,257 | Sold Out | 113,257 | $0.00 |
| Q4 2020 | +78,814 | New Buy | 78,814 | $20.73 |
| Q1 2021 | +41,012 | Add 52.04% | 119,826 | $31.72 |
| Q2 2021 | -4,529 | Reduce 3.78% | 115,297 | $29.38 |
| Q3 2021 | -29,530 | Reduce 25.61% | 85,767 | $27.88 |
| Q4 2021 | +59,478 | Add 69.35% | 145,245 | $27.66 |
| Q1 2022 | +113,430 | Add 78.10% | 258,675 | $22.87 |
| Q2 2022 | -167,367 | Reduce 64.70% | 91,308 | $8.35 |
| Q3 2022 | -13,385 | Reduce 14.66% | 77,923 | $6.94 |
| Q4 2022 | +6,442 | Add 8.27% | 84,365 | $6.27 |
| Q1 2023 | -9,158 | Reduce 10.86% | 75,207 | $8.09 |
| Q2 2023 | +12,481 | Add 16.60% | 87,688 | $8.01 |
| Q3 2023 | +2,474 | Add 2.82% | 90,162 | $8.27 |
| Q4 2023 | -34,939 | Reduce 38.75% | 55,223 | $8.06 |
| Q1 2024 | +15,302 | Add 27.71% | 70,525 | $10.61 |
| Q2 2024 | +177,251 | Add 251.33% | 247,776 | $6.97 |
| Q3 2024 | -12,953 | Reduce 5.23% | 234,823 | $8.16 |
| Q4 2024 | +267,089 | Add 113.74% | 501,912 | $8.06 |
| Q1 2025 | +307,068 | Add 61.18% | 808,980 | $6.47 |
| Q2 2025 | -64,417 | Reduce 7.96% | 744,563 | $6.66 |
| Q3 2025 | -308,010 | Reduce 41.37% | 436,553 | $6.45 |
Ray Dalio's Bausch Health Companies Investment FAQs
Ray Dalio first purchased Bausch Health Companies Inc. (BHC) in Q3 2018, acquiring 169,886 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Bausch Health Companies Inc. (BHC) for 29 quarters since Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Bausch Health Companies Inc. (BHC) was in Q1 2025, adding 808,980 shares worth $5.23 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 436,553 shares of Bausch Health Companies Inc. (BHC), valued at approximately $2.82 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Bausch Health Companies Inc. (BHC) was 808,980 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.